3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Unspecified Adult Solid Tumor, Protocol Specific
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Esophageal Squamous Cell Carcinoma
1
Breast Neoplasms
1
Adenoma, Islet Cell
1
Interventions
Everolimus
3
Bevacizumab
3
Lapatinib
2
vistusertib
1
icotinib
1
Vascular Endothelial Growth Factor A
1
Sunitinib
1
Sirolimus
1
Magnetic Resonance Imaging
1
Exome
1
Endostatins
1
Crizotinib
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neurofibromatosis 2
×
Endostatins
×
Clear all
NCT02104323
2017-02-09
Endostatin
Beijing Tiantan Hospital
Phase 2
Completed
20 enrolled